Hot Features
プレミアム
Upstream Bio Inc (UPB)
NASDAQ
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.24 | -20.7334963325 | 20.45 | 21.13 | 14.97 | 474779 | 18.21329057 | CS |
| 4 | -1.26 | -7.21236405266 | 17.47 | 24.975 | 14.97 | 279076 | 19.82249572 | CS |
| 12 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 26 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 52 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 156 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 260 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
powerbattles
5分前
happyglass
8分前
jeunke22
9分前
jimmy051357
10分前
Zorax
26分前
happyglass
27分前
lakers17
30分前
MoneyMaker111
39分前
awesomed007
40分前
copytele
42分前
Chiugray
43分前
copytele
49分前
Zorax
55分前
ReasearchThis
1時間前
Think1st
1時間前
devil dog 96
1時間前
One11
1時間前
shajandr
1時間前
copytele
1時間前
Not likely
1時間前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
